CLINICAL_TRIALS
trial_result
· 2024-04-30
Clinical Trial Update: ALTO-300 in Depression [Phase 2]
Summary
ALTO-300's Phase 2 trial for Major Depressive Disorder has completed. The update does not include results in the provided snippet.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Alto Neuroscience | Conditions: Major Depressive Disorder | Phase 2 | Status: COMPLETED